GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals

by Shuxin Hu, Aynun N. Begum, Mychica R. Jones, Mike S. Oh, Walter K. Beech, Beverly Hudspeth Beech, Fusheng Yang, Pingping Chen, Oliver J. Ubeda, Peter C. Kim, Peter Davies, Qiulan Ma, Greg M. Cole, Sally A. Frautschy
Published 2009-02-01